Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
11:41am, Thursday, 09'th Apr 2026
CLOV rides strong membership growth and an AI-driven care model, but rising costs and policy risks cloud the near-term outlook.
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
04:05pm, Wednesday, 08'th Apr 2026
WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
08:30am, Tuesday, 07'th Apr 2026
WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed
Clover Health Investments Target of Unusually Large Options Trading (NASDAQ:CLOV)
01:25am, Tuesday, 07'th Apr 2026
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) saw unusually large options trading activity on Monday. Traders acquired 37,742 call options on the stock. This represents an increase
WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives $2.90 Consensus PT from Analysts
03:32am, Monday, 30'th Mar 2026
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) has received an average recommendation of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat reports.
SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clove
Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock
01:20am, Thursday, 19'th Mar 2026
Clover Health is positioned for a major turnaround, with operations and profitability metrics improving sharply despite market skepticism. CLOV projects 46% membership growth and 49% revenue growth fo
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
12:00pm, Thursday, 05'th Mar 2026
CLOV jumped 8% after partnering with Kno2 to become the first payer live on a CMS Aligned Network, enabling real-time patient access to clinical and claims data.
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
01:32pm, Wednesday, 04'th Mar 2026
CLOV rides 38% Medicare Advantage growth and rising EBITDA, but higher medical costs and policy risks cloud its near-term margin outlook.
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
08:30am, Wednesday, 04'th Mar 2026
WILMINGTON, Del., March 04, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed
Critical Comparison: Clover Health Investments (NASDAQ:CLOV) and Strata Skin Sciences (NASDAQ:SSKN)
02:18am, Sunday, 01'st Mar 2026
Strata Skin Sciences (NASDAQ: SSKN - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compar
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
01:46pm, Friday, 27'th Feb 2026
CLOV Q4 loss matches estimates. Revenues jump 45%.
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
07:57pm, Thursday, 26'th Feb 2026
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
